    
  
2025/3/12
                                                                  18 30             1  2                          30 40                                                                                      PSA                                                      60                                                                     CT                                       CEA        AFP      CYFRA 21  1      NSE      CA 19  9                  PSA             CA125      CA 15  3                                      
    